Penn State Department of Family and Community Medicine, Penn State College of Medicine, Hershey (Dr. Malone); Torrance Memorial Physician Network, Calif (Dr. Tsai) malm0001@hotmail.com
The authors reported no potential conflict of interest relevant to this article.
Coffee consumption leads to increased alertness and can boost mental performance. Based on the literature and US Food and Drug Administration recommendations, four 8-oz cups of coffee (about 400 mg of caffeine) daily is an acceptable average amount of caffeine. More than 500 mg/d is considered excessive use of coffee. 33,34
Overall mortality .A 2008 study showed that regular coffee was not associated with increased or decreased mortality in both men and women. 35 However, more recent studies show an inverse relationship between mortality and coffee consumption.
Specifically, a 2014 meta-analysis found an inverse relationship between coffee and mortality. 36 A large prospective cohort study from 2015 that included 79,234 women and 76,704 men found that drinking coffee was inversely associated with overall mortality. 37 In this cohort study, an inverse association were observed for deaths from heart disease, respiratory disease, diabetes, and self-harm. 37 While mechanisms were not analyzed, coffee may reduce mortality risk by affecting inflammation, lung function, insulin sensitivity, and depression.
Cardiovascular disease . Coffee consumption may modestly reduce the risk of stroke, according to a prospective cohort study of 83,076 women from the Nurses’ Health Study who were followed for 24 years. 38 Reduced cardiovascular mortality was also found in a large prospective cohort study, as noted in the mortality discussion above. 37 A 2014 meta-analysis concluded that coffee consumption is inversely associated with cardiovascular mortality. Drinking 3 or 4 cups a day appears to be the amount that may decrease one’s risk of death when compared to those who do not drink coffee at all. 36
Liver disease . Friedrich et al performed a study involving 379 patients with end stage liver disease, and found that coffee consumption delayed the progression of disease in patients with both alcoholic liver disease and primary sclerosing cholangitis. 39Coffee consumption also increased long-term survival after liver transplantation. 39 However, the study found that coffee did not have any effect on patients with chronic viral hepatitis.
In a 2016 meta-analysis, caffeinated coffee consumption reduced hepatic fibrosis of nonalcoholic fatty liver disease, although caffeine consumption did not reduce the prevalence of nonalcoholic fatty liver disease. 40 Another meta-analysis, including 16 studies, also found caffeine reduced the risk for hepatic fibrosis and cirrhosis. 41
Depression. Based on 2 different systematic reviews and meta-analyses from 2016, coffee consumption appears to have a significant protective effect, decreasing the risk of developing depression. 40,42
Alzheimer’s disease/dementia . Coffee, tea, and caffeine consumption show promise in reducing the risk of cognitive decline and dementia. Individuals who consume one to 2 cups of coffee per day had a decreased incidence of mild cognitive impairment compared to non-drinkers. 43 A 2015 Japanese study also found an inverse association between coffee consumption and dementia among women, nonsmokers, and those who do not drink alcohol. 44 Most recently, a 2016 study, the Women’s Health Initiative Memory Study, looked at incident dementia rates in women >65 years of age with high vs low caffeine intake. Women with higher caffeine intake were less likely to develop dementia or any cognitive impairment compared with those consuming <64 mg/day. 45